logo

For the Inventor, By the Inventor

Boonton, NJ, United States of America

Enteris Biopharma, Inc.


USPTO Granted Patents = 13

% Expired Patents = 38.5



Trademarks = 3

Forward Citations = 58

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal William Stern (8 out of 30 patents)

silverMedal Angelo P Consalvo (6 out of 21 patents)

bronzeMedal John Vrettos (4 out of 4 patents)

4.  Thomas A Daggs (3 out of 3 patents)

5.  Paul P Shields (3 out of 3 patents)

6.  Nozer M Mehta (3 out of 37 patents)

7.  Stephen M Carl (3 out of 3 patents)

8.  James P Gilligan (3 out of 24 patents)

9.  Aniruddha M Railkar (2 out of 2 patents)

10.  George R Maurer (2 out of 2 patents)

11.  Phillip Bauer (2 out of 2 patents)

12.  Raymundo Claudio (1 out of 1 patent)

13.  Martha V L Ray (1 out of 10 patents)

14.  Christopher P Meenan (1 out of 11 patents)

15.  Duncan A Miller (1 out of 1 patent)


13 patents:

1. 11998640 - Room temperature stable oral calcitonin formulation (2024-06-04),
2. 11285113 - Room temperature stable oral calcitonin formulation (2022-03-29),
3. 9833411 - Solid oral dosage forms (2017-12-05),
4. 9744140 - Pharmaceuticals for oral delivery (2017-08-29),
5. 9526785 - Pharmaceuticals for oral delivery (2016-12-27),
6. 9504727 - Oral delivery of peptide pharmaceutical compositions (2016-11-29),
7. 9457086 - Pharmaceuticals for oral delivery (2016-10-04),
8. 9399017 - Peptide pharmaceutical for oral delivery (2016-07-26),
9. 8835161 - Bacterial host cell for the direct expression of peptides (2014-09-16),
10. 8815583 - Cell lines for expressing enzyme useful in the preparation of amidated products (2014-08-26),
11. 8664178 - Peptide pharmaceutical for oral delivery (2014-03-04),
12. 8592366 - Peptide pharmaceutical for oral delivery (2013-11-26),
13. 8513183 - Peptide pharmaceutical for oral delivery (2013-08-20),
Company Overview
Enteris Biopharma, Inc. is a biopharmaceutical company based in Boonton, New Jersey, specializing in the development of innovative oral drug delivery solutions. The company focuses on enhancing the bioavailability of therapeutic compounds through its proprietary technologies, which aim to improve patient outcomes and expand treatment options. Enteris is dedicated to advancing its platform for a range of applications, including both small molecules and biologics, thereby addressing significant challenges in the pharmaceutical industry.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Enteris Biopharma, Inc. USPTO Patent Assignee Logo
13 Patents

#5 in Boonton, NJ

#896 in New Jersey

#23,838 in US

#45,039 in the World

Boonton, NJ (US)
Boonton, NJ, United States of America

Enteris Biopharma, Inc.

Forward Citations = 58

15 inventors:

goldMedal William Stern (8 out of 30 patents)

silverMedal Angelo P Consalvo (6 out of 21 patents)

bronzeMedal John Vrettos (4 out of 4 patents)

4.  Thomas A Daggs (3 out of 3 patents)

5.  Paul P Shields (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Enteris Biopharma, Inc.. Retrieved from https://idiyas.com/company/enteris-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…